137 related articles for article (PubMed ID: 26166127)
1. Incidence of Symptomatic Vertebral Fractures Among Newly Diagnosed Autoimmune Diseases Initiating Glucocorticoid Therapy.
Migita K; Iwanaga N; Imadachi S; Jiuchi Y; Izumi Y; Tsuji Y; Kawahara C; Kawakami A; Furukawa H; Tohma S
Medicine (Baltimore); 2015 Jul; 94(27):e875. PubMed ID: 26166127
[TBL] [Abstract][Full Text] [Related]
2. Incidence of symptomatic vertebral fractures in women of childbearing age newly treated with high-dose glucocorticoid.
Sugiyama T; Suzuki S; Yoshida T; Suyama K; Tanaka T; Sueishi M; Tatsuno I
Gend Med; 2010 Jun; 7(3):218-29. PubMed ID: 20638627
[TBL] [Abstract][Full Text] [Related]
3. Age, initial dose and dose increase are independent risk factors for symptomatic vertebral fractures in glucocorticoid-treated male patients.
Sugiyama T; Suzuki S; Yoshida T; Mayama T; Hashimoto N; Suyama K; Tanaka T; Sueishi M; Tatsuno I
Intern Med; 2011; 50(8):817-24. PubMed ID: 21498928
[TBL] [Abstract][Full Text] [Related]
4. Age dependence of early symptomatic vertebral fracture with high-dose glucocorticoid treatment for collagen vascular diseases.
Tatsuno I; Sugiyama T; Suzuki S; Yoshida T; Tanaka T; Sueishi M; Saito Y
J Clin Endocrinol Metab; 2009 May; 94(5):1671-7. PubMed ID: 19258412
[TBL] [Abstract][Full Text] [Related]
5. Incidence of symptomatic vertebral fracture with high-dose glucocorticoid treatment in the Chiba-Shimoshizu Rheumatic Cohort between 1986 and 2006.
Sugiyama T; Tatsuno I; Suzuki S; Yoshida T; Tanaka T; Sueishi M; Saito Y
Endocr J; 2009; 56(4):591-9. PubMed ID: 19352047
[TBL] [Abstract][Full Text] [Related]
6. Rates of serious intracellular infections in autoimmune disease patients receiving initial glucocorticoid therapy.
Migita K; Arai T; Ishizuka N; Jiuchi Y; Sasaki Y; Izumi Y; Kiyokawa T; Suematsu E; Miyamura T; Tsutani H; Kawabe Y; Matsumura R; Mori S; Ohshima S; Yoshizawa S; Kawakami K; Suenaga Y; Nishimura H; Sugimoto T; Iwase H; Sawada H; Yamashita H; Kuratsu S; Ogushi F; Kawabata M; Matsui T; Furukawa H; Bito S; Tohma S
PLoS One; 2013; 8(11):e78699. PubMed ID: 24260127
[TBL] [Abstract][Full Text] [Related]
7. Incident Vertebral Fractures and Risk Factors in the First Three Years Following Glucocorticoid Initiation Among Pediatric Patients With Rheumatic Disorders.
LeBlanc CM; Ma J; Taljaard M; Roth J; Scuccimarri R; Miettunen P; Lang B; Huber AM; Houghton K; Jaremko JL; Ho J; Shenouda N; Matzinger MA; Lentle B; Stein R; Sbrocchi AM; Oen K; Rodd C; Jurencak R; Cummings EA; Couch R; Cabral DA; Atkinson S; Alos N; Rauch F; Siminoski K; Ward LM;
J Bone Miner Res; 2015 Sep; 30(9):1667-75. PubMed ID: 25801315
[TBL] [Abstract][Full Text] [Related]
8. Glucocorticoid Therapy and the Risk of Infection in Patients With Newly Diagnosed Autoimmune Disease.
Migita K; Sasaki Y; Ishizuka N; Arai T; Kiyokawa T; Suematsu E; Yoshimura M; Kawabe Y; Matsumura R; Akagawa S; Mori S; Shirai M; Watanabe Y; Minami N; Soga T; Owan I; Ohshima S; Yoshizawa S; Matsui T; Tohma S; Bito S
Medicine (Baltimore); 2013 Sep; 92(5):285-293. PubMed ID: 23982055
[TBL] [Abstract][Full Text] [Related]
9. Fracture risk in oral glucocorticoid users: a Bayesian meta-regression leveraging control arms of osteoporosis clinical trials.
Amiche MA; Albaum JM; Tadrous M; Pechlivanoglou P; Lévesque LE; Adachi JD; Cadarette SM
Osteoporos Int; 2016 May; 27(5):1709-18. PubMed ID: 26694595
[TBL] [Abstract][Full Text] [Related]
10. Vertebral fracture and bone mineral density in women receiving high dose glucocorticoids for treatment of autoimmune diseases.
Kumagai S; Kawano S; Atsumi T; Inokuma S; Okada Y; Kanai Y; Kaburaki J; Kameda H; Suwa A; Hagiyama H; Hirohata S; Makino H; Hashimoto H
J Rheumatol; 2005 May; 32(5):863-9. PubMed ID: 15868623
[TBL] [Abstract][Full Text] [Related]
11. The threshold of bone mineral density for vertebral fracture in female patients with glucocorticoid-induced osteoporosis.
Kaji H; Yamauchi M; Chihara K; Sugimoto T
Endocr J; 2006 Feb; 53(1):27-34. PubMed ID: 16543669
[TBL] [Abstract][Full Text] [Related]
12. Fracture risk with intermittent high-dose oral glucocorticoid therapy.
De Vries F; Bracke M; Leufkens HG; Lammers JW; Cooper C; Van Staa TP
Arthritis Rheum; 2007 Jan; 56(1):208-14. PubMed ID: 17195223
[TBL] [Abstract][Full Text] [Related]
13. Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy.
Van Staa TP; Laan RF; Barton IP; Cohen S; Reid DM; Cooper C
Arthritis Rheum; 2003 Nov; 48(11):3224-9. PubMed ID: 14613287
[TBL] [Abstract][Full Text] [Related]
14. Predicting the progression of vertebral fractures in patients with multiple myeloma.
Xiao R; Miller JA; Margetis K; Lubelski D; Lieberman IH; Benzel EC; Mroz TE
Spine J; 2016 Apr; 16(4):510-5. PubMed ID: 26704858
[TBL] [Abstract][Full Text] [Related]
15. Assessment of Mortality in Autoimmune Myositis With and Without Associated Interstitial Lung Disease.
Johnson C; Pinal-Fernandez I; Parikh R; Paik J; Albayda J; Mammen AL; Christopher-Stine L; Danoff S
Lung; 2016 Oct; 194(5):733-7. PubMed ID: 27166633
[TBL] [Abstract][Full Text] [Related]
16. A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality.
Hyldgaard C; Hilberg O; Pedersen AB; Ulrichsen SP; Løkke A; Bendstrup E; Ellingsen T
Ann Rheum Dis; 2017 Oct; 76(10):1700-1706. PubMed ID: 28611082
[TBL] [Abstract][Full Text] [Related]
17. Co-morbidity and mortality among patients with interstitial lung diseases: A population-based study.
Hilberg O; Bendstrup E; Løkke A; Ibsen R; Fløe A; Hyldgaard C
Respirology; 2018 Jun; 23(6):606-612. PubMed ID: 29251396
[TBL] [Abstract][Full Text] [Related]
18. Rheumatoid Arthritis Disease Activity Predicting Incident Clinically Apparent Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Prospective Cohort Study.
Sparks JA; He X; Huang J; Fletcher EA; Zaccardelli A; Friedlander HM; Gill RR; Hatabu H; Nishino M; Murphy DJ; Iannaccone CK; Mahmoud TG; Frits ML; Lu B; Rosas IO; Dellaripa PF; Weinblatt ME; Karlson EW; Shadick NA; Doyle TJ
Arthritis Rheumatol; 2019 Sep; 71(9):1472-1482. PubMed ID: 30951251
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of fractures in women with rheumatoid arthritis and/or systemic lupus erythematosus on chronic glucocorticoid therapy.
Rentero ML; Amigo E; Chozas N; Fernández Prada M; Silva-Fernández L; Abad Hernandez MA; Rodriguez Barrera JM; del Pino-Montes J;
BMC Musculoskelet Disord; 2015 Oct; 16():300. PubMed ID: 26472426
[TBL] [Abstract][Full Text] [Related]
20. Vertebral fracture risk with long-term corticosteroid therapy: prevalence and relation to age, bone density, and corticosteroid use.
Naganathan V; Jones G; Nash P; Nicholson G; Eisman J; Sambrook PN
Arch Intern Med; 2000 Oct; 160(19):2917-22. PubMed ID: 11041898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
